Predicted protein targets (top 5)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | LPAR1 | Q92633 | 3/20 | 0.52 |
| ▸ | LPAR3 | Q9UBY5 | 3/20 | 0.52 |
| ▸ | LPAR2 | Q9HBW0 | 1/20 | 0.52 |
| ▸ | FAAH | O00519 | 2/20 | 0.50 |
| ▸ | TRPV1 | Q8NER1 | 1/20 | 0.50 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL26753904 | 1.00 | LPAR1 (0.52) | LPAR1LPAR3LPAR2FAAHTRPV1 | |
| SCHEMBL27512003 | 0.98 | LPAR1 (0.48) | LPAR1LPAR3LPAR2FAAHTRPV1 | |
| SCHEMBL9869504 | 0.96 | FAAH (0.50) | LPAR1LPAR3LPAR2FAAHTRPV1 | |
| SCHEMBL9869502 | 0.96 | FAAH (0.50) | LPAR1LPAR3LPAR2FAAHTRPV1 | |
| SCHEMBL5873974 | 0.93 | FAAH (0.46) | LPAR1LPAR3LPAR2FAAHTRPV1 | |
| SCHEMBL5873976 | 0.93 | FAAH (0.46) | LPAR1LPAR3LPAR2FAAHTRPV1 | |
| SCHEMBL6691272 | 0.91 | FAAH (0.50) | LPAR1LPAR3LPAR2FAAHTRPV1 | |
| SCHEMBL9746911 | 0.91 | MEN1 (0.43) | LPAR1LPAR3LPAR2 | |
| SCHEMBL8482916 | 0.91 | THRB (0.50) | — | |
| SCHEMBL8482915 | 0.91 | THRB (0.50) | — |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-12029790-B2 | Biomimetic nanomaterials and uses thereof | OHIO STATE INNOVATION FOUNDATION (US) | 2024-07-09 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-12029790-B2 | Biomimetic nanomaterials and uses thereof | MTREX, HAVCR2, TSG101 | LPAR1 722/4885LPAR3 1016/4885LPAR2 757/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.